See full Prescribing Info and Important Safety Info in the pinned page post. This page is intended for US healthcare professionals only. © Biogen. All rights reserved. SKY-US-0899 v3.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://hcp.skyclarys.com
- Keywords
- Biogen.
- Competitors
- KEYTRUDA® (pembrolizumab) HCP, HEMLIBRA® (emicizumab-kxwh), Biogen, Salam for Cultural Communication, OCREVUS ZUNOVO® (ocrelizumab and hyaluronidase-ocsq) and OCREVUS® (ocrelizumab), TAGRISSO® (osimertinib) HCP, Peloton Interactive, SFDA - هيئة الغذاء والدواء, DUPIXENT® (dupilumab) HCP, KESIMPTA® (ofatumumab) HCP.
Skyclarys® (Omaveloxolone) 50 Mg Capsules Questions
Skyclarys® (Omaveloxolone) 50 Mg Capsules's website is http://hcp.skyclarys.com
Skyclarys® (Omaveloxolone) 50 Mg Capsules's LinkedIn profile is https://www.linkedin.com/company/skyclarys-hcp
Skyclarys® (Omaveloxolone) 50 Mg Capsules's industry is
Pharmaceutical Manufacturing
Skyclarys® (Omaveloxolone) 50 Mg Capsules's top competitors are
Keytruda® (Pembrolizumab) Hcp,
Hemlibra® (Emicizumab-Kxwh),
Biogen,
Salam For Cultural Communication,
Ocrevus Zunovo® (Ocrelizumab And Hyaluronidase-Ocsq) And Ocrevus® (Ocrelizumab),
Tagrisso® (Osimertinib) Hcp,
Peloton Interactive,
Sfda - هيئة الغذاء والدواء,
Dupixent® (Dupilumab) Hcp,
Kesimpta® (Ofatumumab) Hcp.
Skyclarys® (Omaveloxolone) 50 Mg Capsules's categories are Pharmaceutical Manufacturing
